The MYCN Oncogene as a Specific and Selective Drug Target for Peripheral and Central Nervous System Tumors
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
273-283
Author(s):
Andrea Pession and Roberto Tonelli
Adrenomedullin in Hypertension
Journal:
Current Hypertension Reviews
Volume:
1
Page:
169-181
Author(s):
Toshio Nishikimi and Hiroaki Matsuoka
Cellular and Biochemical Alterations Caused by Artificial Depletion of Glutathione
Journal:
Current Enzyme Inhibition
Volume:
1
Page:
123-130
Author(s):
N. Tolosa de Talamoni, A. Marchionatti, G. Diaz de Barboza and A. Perez
Oxidative Stress, Antioxidants and Neurodegenerative Diseases
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
2033-2052
Author(s):
I. Casetta, V. Govoni and E. Granieri
Management of the Menopausal Disturbances and Oxidative Stress
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
2063-2073
Author(s):
Francesco Pansini, Gioacchino Mollica and Carlo M. Bergamini
Metallic Colloid Nanotechnology, Applications in Diagnosis and Therapeutics
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
2091-2105
Author(s):
Fabio Sonvico, Catherine Dubernet, Paolo Colombo and Patrick Couvreur
Targeting the G2/M Transition for Antitumor Therapy
Journal:
Letters in Drug Design & Discovery
Volume:
2
Page:
274-281
Author(s):
J. Yuan and K. Strebhardt
Cytoprotection by Melatonin, Precursors and Metabolites in an In Vitro Model of Neurotoxicity Induced by Okadaic Acid
Journal:
Letters in Drug Design & Discovery
Volume:
2
Page:
316-321
Author(s):
I. Tunez, R. Drucker-Colin, M. C. Munoz and P. Montilla
Dynamic Medicinal Chemistry in the Elaboration of Morphine-6- Glucuronide Analogs
Journal:
Current Topics in Medicinal Chemistry
Volume:
5
Page:
585-594
Author(s):
John R. Cashman and James M. MacDougall
Neurotrophic Actions of Mood-Stabilizers: A Recent Research Discovery and its Potential Clinical Applications
Journal:
Current Psychiatry Reviews
Volume:
1
Page:
173-185
Author(s):
Guang Chen, Thomas Creson, Sharon Engel, Yanlei Hao and Gang Wang